Oncolytic virus

Results: 117



#Item
41NATIONAL ACADEMY OF SCIENCES

NATIONAL ACADEMY OF SCIENCES

Add to Reading List

Source URL: www.fda.gov

Language: English
42HSV1716 (SEPREHVIR R ) NIH RAC June 11, 2013 Timothy P. Cripe, M.D., Ph.D. Chief, Division of Hematology/Oncology/BMT Nationwide Children’s Hospital

HSV1716 (SEPREHVIR R ) NIH RAC June 11, 2013 Timothy P. Cripe, M.D., Ph.D. Chief, Division of Hematology/Oncology/BMT Nationwide Children’s Hospital

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-13 12:04:14
43September 2011 Global recognition for cancer researcher at The Ottawa Hospital In a world-first cancer therapy trial, Dr. John Bell, a senior scientist at the Ottawa Hospital Research Institute (OHRI), has shown that a g

September 2011 Global recognition for cancer researcher at The Ottawa Hospital In a world-first cancer therapy trial, Dr. John Bell, a senior scientist at the Ottawa Hospital Research Institute (OHRI), has shown that a g

Add to Reading List

Source URL: fondationho.ca

Language: English - Date: 2012-05-07 14:27:17
44Microsoft PowerPoint - RAC presentation_629_PI.ppt

Microsoft PowerPoint - RAC presentation_629_PI.ppt

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-16 11:19:46
45Protocol #[removed]: Phase I Trial of Intratumoral Injection of Vesicular Stomatitis Virus Expressing Interferon Beta in Patients with Hepatocellular Carcinoma PI: Mitesh J. Borad, M.D., Mayo Clinic, Scottsdale, AZ Jorge

Protocol #[removed]: Phase I Trial of Intratumoral Injection of Vesicular Stomatitis Virus Expressing Interferon Beta in Patients with Hepatocellular Carcinoma PI: Mitesh J. Borad, M.D., Mayo Clinic, Scottsdale, AZ Jorge

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-06 11:35:11
46Phase I Dose Escalation Trial of Intratumoral Injection with Oncolytic Adenovirus Vector INGN 007 (VRX-007) in Patients with Advanced Solid Tumors Principal Investigator: John Nemunaitis, M.D.

Phase I Dose Escalation Trial of Intratumoral Injection with Oncolytic Adenovirus Vector INGN 007 (VRX-007) in Patients with Advanced Solid Tumors Principal Investigator: John Nemunaitis, M.D.

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-10 10:41:51
47Protocol No: BC[removed]Phase 1/2a, Dose-Escalation, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Intraperitoneal Administration of DTA-H19 in Subjects with Advanced Stage Ovarian Cancer  Presentation to the

Protocol No: BC[removed]Phase 1/2a, Dose-Escalation, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Intraperitoneal Administration of DTA-H19 in Subjects with Advanced Stage Ovarian Cancer Presentation to the

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-06 12:50:54
48Microsoft PowerPoint - 625_Alvarez.ppt

Microsoft PowerPoint - 625_Alvarez.ppt

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-16 11:21:44
49Microsoft PowerPoint - Doroshow.pptx

Microsoft PowerPoint - Doroshow.pptx

Add to Reading List

Source URL: deainfo.nci.nih.gov

Language: English - Date: 2012-02-03 08:49:45
50RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting March 9-11, 2004 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service

RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting March 9-11, 2004 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-16 11:18:35